Factors associated with nodal pathologic complete response among breast cancer patients treated with neoadjuvant chemotherapy: results of CALGB 40601 (HER2+) and 40603 (triple-negative) (Alliance)
- Citation:
- Ann Surg Oncol vol 28 (11) 5960-71
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- 3482
- Children:
- None
- Pharmas:
- Glaxo Smith Kline (40601) and Genentech (40603)
- Grants:
- U10CA180821, U10CA180882, UG1CA233178, UG1CA233180, UG1CA233253, UG1CA233337, UG1CA233373
- Corr. Author:
- Authors:
- Anna Weiss Jordan Campbell Karla V. Ballman William M. Sikov Lisa A. Carey E. Shelley Hwang Matthew M. Poppe Ann H. Partridge David W. Ollila Mehra Golshan
- Networks:
- LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NC010, LAPS-UT003, NY167, RI005
- Study
- Alliance-A151942
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-40601, CALGB-40603
- Phases:
- N/A, 2, 3
- Keywords: